Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patrizia Terzano is active.

Publication


Featured researches published by Patrizia Terzano.


Gynecologic Oncology | 2003

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization

Silvano Costa; Pia De Simone; Simona Venturoli; Monica Cricca; Maria Luisa Zerbini; Monica Musiani; Patrizia Terzano; Donatella Santini; Paolo Cristiani; Stina Syrjänen; Kari Syrjänen

OBJECTIVE The objective was to identify the factors, if any, that may predict long-term results of CIN treatment and HPV clearance/persistence after locally excisional therapy. METHODS A series of 252 women with CIN lesions treated by conization were subjected to sequential HPV detection by repeated PCR during the prospective posttreatment follow-up. Factors predicting viral clearance during the follow-up (10.26 months) were elaborated using univariate and multivariate statistical techniques applied on epidemiological, clinical and biological data of the lesions. RESULTS Sensitivity of the PAP test in detecting high-grade lesions was 93.9%, and specificity 27.3%. Odds ratio for having CIN 3/Stage IA1 squamous cervical cancer in the cone with HSIL PAP test was 5.69; 77.8 and 22.2% residual disease were found among PCR-positive and -negative cases, respectively. HPV DNA was negative in 74/252 (29.8%) samples at the first PCR. Multivariate logistic regression analysis showed that HPV 16 was an independent explanatory factor for high-grade CIN (P = 0.0001). HPV clearance increased to 63.5% at completion of the follow-up, corresponding to the monthly clearance rate of 5.27%. In Kaplan-Meier analysis, the highly significant (P = 0.0001) predictors of HPV clearance/persistence were age, lesion grade in the biopsy, lesion grade in the cone, volume of the cone, length of active sexual life, and involvement of endocervical margin (P = 0.0013). In chi-square tests, high-risk HPV type (P = 0.001) was such a predictor. In multivariate (Cox) model, the significant independent predictors of HPV clearance were involved endocervical margin (P = 0.001), lesion grade in the cone (P = 0.004), high-grade lesion in the colposcopic biopsy (P = 0.023), age (P = 0.029), and HSIL in PAP smear (P = 0.029). CONCLUSIONS These data suggest that posttreatment follow-up should include both the PAP test and HPV detection techniques for early detection of any patients at increased risk for disease recurrence and progression, because of persistent oncogenic HPV types.


American Journal of Clinical Pathology | 2001

Neoadjuvant Chemotherapy in Cervical Carcinoma Regulators of Cell Cycle, Apoptosis, and Proliferation as Determinants of Response to Therapy and Disease Outcome

Silvano Costa; Patrizia Terzano; Donatella Santini; Claudio Ceccarelli; A. Martoni; Bruna Angelelli; Achille Panetta; Alessandro Bovicelli; Paolo Cristiani; Lipponen P; Mojca Erzén; Stina Syrjänen; Kari Syrjänen

To evaluate whether cellular markers predict the responsiveness to neoadjuvant chemotherapy (NAC) in cervical cancer, 21 patients with stages I and II cervical carcinomas treated by NAC before surgery were followed up for a mean of 52.3 months. Pre-NAC biopsy and operative specimens were subjected to counting of apoptotic (AI/V) and mitotic (MI/V) indices, detection of human papillomavirus (HPV) DNA, and immunohistochemical analysis of cell cycle and proliferation markers (p21, p53, pRb, proliferating cell nuclear antigen [PCNA], Ki-67) and multidrug resistance gene (MDR1), as related to NAC response (RAC), recurrence-free (RFS), and overall (OS) survival. Adenosquamous histology and lymph node involvement were significant determinants of nonsurvival. All carcinomas contained HPV DNA. In univariate analysis, p21, pRb, and MDRI in the biopsy specimen and PCNA, Ki-67, and pRb in the surgical sample significantly predicted RAC, while age, AI/V number of lymph nodes removed, and MI/V predicted RFS. Highly significant predictors of OS were AI/V number of lymph nodes removed, post-NAC MDR1 expression, MI/V and recurrence. Multivariate analysis confirmed the strong post-NAC effects of histologic type, AI/V, and MDR1 expression for RFS, and recurrence, age, and Ki-67 expression for OS. NAC responders with slightly decreased AI/V and increased MI/V had a poor prognosis.


Acta Cytologica | 2000

Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.

Silvano Costa; M. Sideri; K. Syrjänen; Patrizia Terzano; M. de Nuzzo; P. de Simone; Paolo Cristiani; A. C. Finarelli; Alessandro Bovicelli; Alessandra Zamparelli; Luciano Bovicelli

OBJECTIVE The sensitivity of the Pap smear (PAP) continues to be the subject of debate. During the past several years, cervicography (CER) and HPV DNA testing have been suggested as optional tools in the screening of cervical cancer precursors. STUDY DESIGN The performance characteristics of PAP, CER and HPV DNA testing (hybrid capture test [HCT]) in all potential combinations were evaluated in a series of 1,030 women (aged 16-70, median, 33), subjected to colposcopy (COLPO) as the reference tool. RESULTS Of the 992 evaluable cases, 402/992 (41%) had positive COLPO (i.e., an abnormal transformation zone). Of them, 298 women underwent directed punch biopsy, while of the COLPO negative patients, 18/93 positive by at least one of the three tests had endocervical curettage. Of the 402 COLPO positive women, 146 (36%) remained negative on all tests, whereas 256 (64%) had at least one positive test. There were 84 cervical intraepithelial neoplasia (CIN) 2 and 3 lesions and 6 invasive carcinomas. Of the former, 10 were detected by PAP alone, 4 by CER alone and 3 by HCT alone. Three of the 6 carcinomas were HCT negative. The predictive value (PPV) of a positive test was 45% for PAP, 51% for CER and 48% for HCT. The combinations of PAP with CER (for PAP negative cases) and PAP with HCT were more sensitive for CIN 2 and 3 (95% and 94%, respectively) as compared with PAP alone but were associated with a significant decrease in specificity (44% and 46% vs. 57%, respectively). However, both combinations retained a PPV (43%) similar to that of PAP alone (45%). CONCLUSION The potential combinations of PAP with CER and with HCT were more sensitive in detecting CIN 2 and 3 as compared with PAP alone and retained a PPV similar to that of PAP.


European Journal of Clinical Microbiology & Infectious Diseases | 1985

Detection of active Epstein-Barr infection in pregnant women

Silvano Costa; R. Barrasso; Patrizia Terzano; Maria Luisa Zerbini; C. Carpi; Monica Musiani

Sera taken from pregnant patients and their newborns at delivery were examined for evidence of primary or reactivated Epstein-Barr virus infection. Of 102 women, 37 showed serological signs of reactivated and two signs of primary infection. A mild congenital defect was observed in association with one of the two cases of maternal primary infection. Infants of mothers with reactivated infections remained healthy during the one year follow-up after birth.


Acta Obstetricia et Gynecologica Scandinavica | 2000

Factors associated with cone margin involvement in CIN patients undergoing conization-equivalent electrosurgical procedure.

Silvano Costa; Maria De Nuzzo; Patrizia Terzano; Donatella Santini; Pia De Simone; Alessandro Bovicelli; Luciano Bovicelli; Lauro Bucchi

Background. Most studies of cervical conization have considered the frequency of complications and the outcome of follow‐up. The determinants of cone margin positivity have been inadequately described. In a series of CIN patients undergoing conization‐equivalent electrosurgical procedure, we evaluated the factors associated with (i) any cone margin involvement, and (ii) endocervical margin involvement (with or without other locations) as contrasted with all other conditions.


European Journal of Epidemiology | 1994

Impact of sexual habits on the clinical evaluation of male HPV infection

Antonella Rotola; Silvano Costa; P. Monini; C. Vendra; G. Guida; Patrizia Terzano; D. Di Luca; G. Martinelli; Enzo Cassai

A series of 199 male regular sexual partners of women attending an STD clinic for the examination and treatment of HPV-associated diseases was examined by peniscopy, surgical biopsy and nucleic acid hybridization for the presence of clinical, histological and molecular markers pathognomic of HPV infection. There was a 100% correlation between condylomata acuminata and detection of HPV type 6 or 11 DNA. Papillary lesions displayed neither histological signs of HPV infection, nor did they harbor HPV DNA (viral types 6, 11, 16, 18, 33) while 44.9% (22/49) of acetowhite epithelia showed HPV-suggestive histological changes. Of the 19 analysed for HPV DNA, 15.8% (3/19) harbored HPV 6/11 and 16 DNA. Regular male and female sexual partners did not always harbor the same HPV types, showing that latent or occult infection and the sexual habits of each individual play an important role in the clinical manifestations of HPV infection observed in sexual couples. The present data show that: i) the likelihood of developing a clinical HPV lesion was affected, to a large extent, by the previous sexual history and habits in the partners of women with flat condylomata, while partners of women with condylomata acuminata or CINs displayed a higher correlation with the current state of infection in their regular partner; ii) despite the assessed infective state of their consorts, men with a low lifetime number of sexual partners seldom displayed HPV-associated acetowhitening. Prevalence of such lesions, however, increased significantly with an increase in the total number of sexual partners; iii) clinical assessment and evaluation of HPV-risk for inconspicuous penile lesions in the male partner should be carried out not only on the basis of clinical and peniscopic appearance, but also considering the current state of infection in the regular partner and the sexual history and habits of each individual.


Human Pathology | 2001

Expression of cell-cycle–associated proteins pRB2/p130 and p27kip1 in vulvar squamous cell carcinomas

Alessandra Zamparelli; Valeria Masciullo; Alessandro Bovicelli; Donatella Santini; Gabriella Ferrandina; Corrado Minimo; Patrizia Terzano; Silvano Costa; Caterina Cinti; Claudio Ceccarelli; Salvatore Mancuso; Giovanni Scambia; Luciano Bovicelli; Antonio Giordano


International Journal of Cancer | 1989

Search for human papillomavirus, herpes simplex virus and c‐myc oncogene in human genital tumors

D. Di Luca; Silvano Costa; P. Monini; Antonella Rotola; Patrizia Terzano; A. Savioli; W. Grigioni; Enzo Cassai


Gynecologic Oncology | 2001

CD44 Isoform 6 (CD44v6) Is a Prognostic Indicator of the Response to Neoadjuvant Chemotherapy in Cervical Carcinoma

Silvano Costa; Patrizia Terzano; Alessandro Bovicelli; A. Martoni; Bruna Angelelli; Donatella Santini; Claudio Ceccarelli; Lipponen P; Mojca Erzén; Stina Syrjänen; Kari Syrjänen


Gynecologic Oncology | 1995

Presurgical Assessment and Therapy of Microinvasive Carcinoma of the Cervix

Camillo Orlandi; Silvano Costa; Patrizia Terzano; Giuseppe Nicolamartinelli; Giuseppe Comerci; Brunella Guerra; Loredana Martellini

Collaboration


Dive into the Patrizia Terzano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge